NCT01357538

Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis

Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis - a Multi-centre, Randomised, Double-masked, Parallel-group, Phase IV Comparison

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 197 (actual)
• Sponsor: Ursapharm Arzneimittel GmbH · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.

Detailed description

Reduction of signs and symptoms of blepharitis

Conditions

• Blepharitis
• Signs and Symptoms

Interventions

Type	Name	Description
DRUG	Posiformin 2 %, bibrocathol	A strip of 5 mm eye ointment applied 3 times per day to the eye lid
DRUG	Placebo Comparator	corresponding vehicle, eye ointment applied to the eye lid

Timeline

• Start date: 2009-02-01
• Primary completion: 2009-07-01
• Completion: 2009-08-01
• First posted: 2011-05-20
• Last updated: 2011-05-20

Locations

1 site across 1 country: Ukraine